Clinical Trials Browser

Phase 2 × Adenocarcinoma × Lapatinib × Clear all

NCT00259987 2009-05-18

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Phase 2 Completed

Adenocarcinoma, Neoplasms